ELMWOOD PARK, N.J., November 29, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), announced COVID-19 testing preparedness for the Omicron Variant. BioReference’s PCR diagnostic tests for SARS-CoV-2 COVID-19 are based on recognizing specific RNA target genes that are common to all coronaviruses. To date, the diagnostic targets have not changed with the novel […]
Search Results for: NEW
29
Nov
Nov
According to the Centers for Disease Control and Prevention (CDC), outdoor activities are still safer to take part in than indoor activities due to COVID-19.1 Though, with chilly weather settling in in many regions, this may mean changing some of our go-to adventures. Luckily, fall and winter bring a host of new opportunities to enjoy […]
23
Nov
Nov
Thanksgiving brings the beginning of the winter holiday season – a time for connection and celebration. As family gathers around the table to give thanks, a toast to health is often in order. This year, take the opportunity to touch base with your loved ones about important familial health matters like cancer screening for hereditary […]
21
Oct
Oct
Exciting news for Android users. We previously shared that Apple users can access test results through Apple Health. Now, Android users can do the same through the CommonHealth mobile application. BioReference Laboratories now supports access to test results through CommonHealth on Android devices. This new offering makes it easy to centralize your health records from […]
PM360 Hillary M. Titus, Director of External Communications, BioReference Laboratories, Inc. As the world’s leading diagnostics labs raced to develop effective COVID-19 testing programs, BioReference Laboratories’ existing proprietary technology was already far ahead of the competition. However, the small lab was virtually unknown. In order to launch new testing services, BioReference had to become part […]
18
Oct
Oct
In honor of Breast Cancer Awareness Month, Terri offers her perspective on her breast cancer treatment, the positive attitude and silver-lining she discovered through her journey.
06
Oct
Oct
ELMWOOD PARK, NJ and Chicago, IL (October 6, 2021) – BioReference Laboratories’ Richard Schwabacher is among Modern Healthcare’s 2021 class of Top 25 Emerging Leaders. Modern Healthcare, the leader in healthcare business news, research and data, annually honors emerging leaders all age 40 or under, who have made significant contributions in the areas of innovation […]
05
Oct
Oct
Every October, people all around the world join together for breast cancer awareness and show support for those affected by breast cancer. Women in the U.S. have a 1 in 8 lifetime risk of being diagnosed with breast cancer[i]. While it is the most common cancer in American women (except for skin cancer), death rates […]
20
Sep
Sep
As data from public health entities continues to emerge about COVID-19 and the Delta variant, we have learned it is more infectious and leading to increased transmissibility when compared with other variants. With the Delta variant accounting for more than 93% of new COVID-19 cases and being more than 2x as contagious as previous variants, according […]
